Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.

PHASE3CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

September 20, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

March 27, 2019

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

semaglutide

Oral administration once-daily.

DRUG

sitagliptin

Oral administration once-daily.

Trial Locations (83)

1130

Novo Nordisk Investigational Site, Vienna

1200

Novo Nordisk Investigational Site, Brussels

1211

Novo Nordisk Investigational Site, Geneva

2317

Novo Nordisk Investigational Site, Hamar

2650

Novo Nordisk Investigational Site, Edegem

2820

Novo Nordisk Investigational Site, Bonheiden

3000

Novo Nordisk Investigational Site, Leuven

3010

Novo Nordisk Investigational Site, Bern

3400

Novo Nordisk Investigational Site, Corrientes

4000

Novo Nordisk Investigational Site, Liège

4011

Novo Nordisk Investigational Site, Stavanger

4600

Novo Nordisk Investigational Site, Olten

6000

Novo Nordisk Investigational Site, Lucerne

7027

Novo Nordisk Investigational Site, Trondheim

7300

Novo Nordisk Investigational Site, Boussu

8036

Novo Nordisk Investigational Site, Graz

8401

Novo Nordisk Investigational Site, Winterthur

8511

Novo Nordisk Investigational Site, Saint Stefan

8840

Novo Nordisk Investigational Site, Einsiedeln

9000

Novo Nordisk Investigational Site, Ghent

9007

Novo Nordisk Investigational Site, Sankt Gallen

9016

Novo Nordisk Investigational Site, Sankt Gallen

11562

Novo Nordisk Investigational Site, Cairo

11591

Novo Nordisk Investigational Site, Cairo

15236

Novo Nordisk Investigational Site, Pittsburgh

15355

Novo Nordisk Investigational Site, Gyeonggi-do

16499

Novo Nordisk Investigational Site, Suwon

20745

Novo Nordisk Investigational Site, Oxon Hill

21131

Novo Nordisk Investigational Site, Alexandria

23321

Novo Nordisk Investigational Site, Chesapeake

26426

Novo Nordisk Investigational Site, Gangwon-do

27408

Novo Nordisk Investigational Site, Greensboro

27514

Novo Nordisk Investigational Site, Chapel Hill

27834

Novo Nordisk Investigational Site, Greenville

28472

Novo Nordisk Investigational Site, Whiteville

29572

Novo Nordisk Investigational Site, Myrtle Beach

29576

Novo Nordisk Investigational Site, Murrells Inlet

30318

Novo Nordisk Investigational Site, Atlanta

32127

Novo Nordisk Investigational Site, Port Orange

33014

Novo Nordisk Investigational Site, Miami Lakes

33461

Novo Nordisk Investigational Site, Lake Worth

33472

Novo Nordisk Investigational Site, Boynton Beach

33607

Novo Nordisk Investigational Site, Tampa

33614

Novo Nordisk Investigational Site, Tampa

34096

Novo Nordisk Investigational Site, Istanbul

34722

Novo Nordisk Investigational Site, Istanbul

34752

Novo Nordisk Investigational Site, Istanbul

34890

Novo Nordisk Investigational Site, Istanbul

34899

Novo Nordisk Investigational Site, Istanbul

37660

Novo Nordisk Investigational Site, Kingsport

40213

Novo Nordisk Investigational Site, Louisville

44060

Novo Nordisk Investigational Site, Mentor

44122

Novo Nordisk Investigational Site, Cleveland

44281

Novo Nordisk Investigational Site, Wadsworth

46140

Novo Nordisk Investigational Site, Greenfield

47304

Novo Nordisk Investigational Site, Muncie

48504

Novo Nordisk Investigational Site, Flint

53020

Novo Nordisk Investigational Site, Rize

59101

Novo Nordisk Investigational Site, Billings

70002

Novo Nordisk Investigational Site, Metairie

75231

Novo Nordisk Investigational Site, Dallas

78413

Novo Nordisk Investigational Site, Corpus Christi

83221

Novo Nordisk Investigational Site, Blackfoot

85050

Novo Nordisk Investigational Site, Phoenix

91304

Novo Nordisk Investigational Site, West Hills

93534

Novo Nordisk Investigational Site, Lancaster

98057

Novo Nordisk Investigational Site, Renton

85306-4652

Novo Nordisk Investigational Site, Glendale

60201-2477

Novo Nordisk Investigational Site, Evanston

89052-2649

Novo Nordisk Investigational Site, Henderson

87109-2134

Novo Nordisk Investigational Site, Albuquerque

C1180AAX

Novo Nordisk Investigational Site, CABA

S2000DNM

Novo Nordisk Investigational Site, Rosario

01228-200

Novo Nordisk Investigational Site, São Paulo

0373

Novo Nordisk Investigational Site, Oslo

0586

Novo Nordisk Investigational Site, Oslo

602-739

Novo Nordisk Investigational Site, Pusan

03080

Novo Nordisk Investigational Site, Seoul

03722

Novo Nordisk Investigational Site, Seoul

08308

Novo Nordisk Investigational Site, Seoul

01130

Novo Nordisk Investigational Site, Adana

06100

Novo Nordisk Investigational Site, Ankara

07058

Novo Nordisk Investigational Site, Antalya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY